Ordinance on Prevention of Hazards Due to
Specified Chemical Substances
Ministry of Labour Ordinance No.
39 of September 30, 1972
|
Supplementary Provisions
(Date of Enforcement)
Article 1.
This Ministry of Labour Ordinance will be put into effect on October
1, 1972, provided that this does not apply in respect to Article 4,
which will be put into effect on October 1, 1973.
(Abrogation)
Article 2.
The Ordinance on Prevention of Hazards Due to Specified Chemical Substances,
etc. (Ministry of Labour Ordinance No. 11 of 1971) will be abolished.
(Interim Measures concerning Local Exhaust Ventilation
Systems)
Article 3.
In terms of indoor workshops where dispersion occurs of the dust of
coal tar, the provisions as set forth in Article 5 will not be applied
to the workshops until September 30, 1973.
(Interim Measures concurring Dust Exclusion Devices)
Article 4.
In term of exhaust gas disposition cylinders from which to emit the
gases containing dusts of coal tar, the provision of Article 9 will
not be applied until September 30. 1973.
(Interim Measures concurring Operations Chiefs
of Work on Specified Chemical Substances, etc.)
Article 5.
In spite of the provisions of Article 27, the employer may appoint
an operations chief of work on specified chemical substances, etc.,
from among persons holding the health supervisor's license until September
30, 1974.
Supplementary Provisions
(Ministry of Labour Ordinance No. 26 of
September 30, 1975)
(Date of Enforcement)
Article 1.
This Ministry of Labour Ordinance will be put into effect on October
1, 1975, provided that the following provisions will be put into effect
on the dates shown in the respective items.
(1) Amended provision of contents
(exclusive of the portion thereby to revise "Article 50"
into "Article 50-2"), amended provision thereby to add one
article following Article 12, amended provision thereby to revise
Article 20 (exclusive of the portions thereby to revise "item
(8)" into "item (9)," "item (7)" into "item
(8)," and to add one item following item (6), amended provisions
thereby to revise Article 22, Article 24 and Article 25, amended provision
thereby to add three articles following Article 38, amended provision
thereby to add one chapter next to Chapter V (exclusive of the portions
related to Article 38-9 and Article 38-12), amended provision thereby
to add one article following Article 52, and amended provision thereby
to add the form following Form No. 10: January 1, 1976.
(2) Amended provisions thereby
to revise Article 3, the heading before Article 4 and Article 4, amended
provisions thereby to revise Article 6, (restricted to that of "The
provisions of the preceding Article, indoor workshops" into "The
provisions of the preceding two Articles, indoor workshops"),
amended provision thereby to revise paragraph 1 of Article 7 (exclusive
of the portions thereby to add provisos to item (3), and also add
one item to the same paragraph), amended provisions thereby to revise
Article 8 (restricted to the revision of "paragraph 3 of Article
3, and Article 4" into "Article 3, and paragraph 3 of Article
4), amended provision thereby to revise Article 9 (restricted to revision
of "paragraph 3 of Article 3, and Article 4" into "Article
3, and paragraph 3 of Article 4"), amended provision thereby
to revise Article 10 (restricted to "paragraph 1 of Article 5"
into "paragraph 3 of Article 4 or paragraph 1 of Article 5"),
amended provisions thereby to revise paragraph 2 of Article 11, Article
13, and Article 15 to 17 inclusive, amended provision thereby to add
one Article following Article 18, amended provision thereby to revise
Article 19, amended provision thereby to add two articles following
Article 19, amended provision thereby to revise Article 20 (restricted
to the revision of item (8) of Article 20 into item (9) of Article
20, and also of "item (7) of Article 20" into "item
(8) of Article 20," and also the addition of one item following
item (6) of Article 20), amended provision thereby to revise the Article
21 (restricted to the portions related to the group-2 substances under
supervision of the portions in which to revise the specified group-1
substances into auramine, etc., or group-2 substances under supervision),
amended provision thereby to revise Article 29 (restricted to the
portions, related to Article 3 and paragraph 3 of Article 4, of the
portions in which to revise paragraph 3 of Article 3, Article 4 or
paragraph 1 of Article 5 into Article 3, paragraph 3 of Article 4,
paragraph 1 of Article 5 or item (2) of paragraph 1 of Article 38-9
as set forth in item 1 of paragraph 1 of Article 29, and addition
of "inclusive of local exhaust ventilation systems as set forth
in the provisos in paragraph 1 of Article 3 and paragraph 1 of Article
38-12" to the portion following "local exhaust ventilation
systems," and amended provisions thereby to add one chapter following
Chapter V (restricted to the portions related to Article 38-12): April
1,1976.
(3) Amended provisions thereby
to revise Article 29 (restricted to the portion related to item 2
of paragraph 1 of Article 38-9, of the portions in which to revise
"paragraph 3 of Article 3, Article 4 or paragraph 1 of Article
5" as set forth in item (1) of paragraph 1 of Article 29, into
"Article 3, paragraph 3 of Article 4, paragraph 1 of Article
5 or item (2) of paragraph 1 of Article 38-9," and also to add
"or item (3) of paragraph 1 of Article 38-9" to the portion
following "paragraph 1 of Article 9" as set forth in item
2 of paragraph 1 of Article 29, and amended provision thereby to add
one chapter following Chapter V (restricted to the portion related
to Article 38-9): April 1, 1977
(Interim Measures)
Article 2.
In terms of the application of paragraph 1 of Article 5 of the newly
revised Ordinance on Prevention of Hazards Due to Specified Chemical
Substances, etc. (hereinafter called the "New Ordinance"),
the portion of paragraph 1 of Article 5, which says that "indoor
workshops when manufacturing specified group-2 substances, when handling
the said group-2 substances in workshops therein to manufacture specified
group-2 substances, where conducting fumigation therein to handle
substances as set forth in (17) to (20) inclusive of item 2 in Attached
Table 3 of the Enforcement Order or substances as described in item
(17) to (20) inclusive in Attached Table 1 (hereinafter called methyl
bromide, etc.), and when handling the substances as set forth in (30)
of item 2 in Attached Table 3 or substances (hereinafter called "benzene,
etc.") as described in item (30) in Attached Table 1 (inclusive
of dilutants, similarly as in Article 38-12), the indoor workshops
are excluded from which dispersion is made of gases, vapour or powdered
dust of the specified group-2 substances" shall be defined as
"indoor workshops" by December 31, 1975.
2. In terms of the provisos of paragraph
1 of Article 5 of the New Ordinance, the portion of paragraph 1 of
Article 5, which says that "indoor workshops (when manufacturing
specified group-2 substances, when handling the specified group-2
substances in workshops therein to manufacture the specified group-2
substances, when performing fumigation therein to handle the substances
or set forth in (17) or (20) of item 2 in Attached Table 3 of the
Enforcement Order or substances listed in (17) or (20) of item 2 of
Attached Table 1 (hereinafter called "methyl bromide"),
and when handling the substances listed in the (30) of item 2 in Attached
Table 3 or the substances as described in item (30) in Attached Table
1 (hereinafter called "benzene, etc.") the indoor workshops
are excluded from which dispersion is made of gases, vapour or powdered
dust of specified group-2 substances" shall be defined as "indoor
workshops (when conducting fumigation therein to handle the substances
listed in (17) or (20) of item 2 in Attached Table 3 of the Enforcement
Order or substances listed in item (17) or (20) in Attached Table
1, the indoor workshops are excluded from which dispersion is made
of gases of these substances)" for the period of January 1, 1976
to March 31, 1976.
3. In terms of application of Article 3
and Article 4 of the old Ordinance on Prevention of Hazards Due to
Specified Chemical Substances, "specified group-1 substances"
as set forth in Article 3 shall be defined as "Auramine, etc.,"
and "permitted substances" as described in Article 4 shall
be defined as "group-1 substances (exclusive of substances listed
in (3) of item 1 of Attached Table 3 of the Enforcement Order or substances
listed in (7) of item 1 in the same Table, and as related to 3 of
the same item) " respectively, until March 31, 1976.
4.
When the employer performs work to put the substances, listed in (3)
of item 1 in Attached Table 3 of the Enforcement Order of the Industrial
Safety and Health Law, or substances (hereinafter called "chlorobiphenyl
, etc." in this paragraph) listed in (7) of item 1 in the same
Table and as related to 3 of the same item into containers, to take
these substances out of containers or to throw the substances into
reaction vessels (in the workshops therein to manufacture chlorobiphenyl,
the exclusion is made of the work thereby to put chlorobiphenyl into
its containers, to take the chemical out of the containers or to throw
the chemical into reaction vessels), the said workshops shall be provided
with local exhaust ventilation systems.
5. In terms of the application of the provisions
set forth in Article 7, Article 8 and paragraph 1 of Article 29 of
the New Ordinance on the local exhaust ventilation systems as provided
in compliance with the provisions in the preceding paragraph, the
said local exhaust ventilation systems will be regarded as the ones
provided in compliance with paragraph 1 of Article 5 of the New Ordinance.
6. As for the facilities thereby to manufacture
the substances listed in 6 of item 2 of Attached Table 3 of the Enforcement
Order of the Industrial Safety and Health Law or the substances listed
in item 6 in Attached Table 1 of the New Ordinance, or to handle these
substances, actually existing on March 31, 1978, the said facilities
are not applied to the provisions as described in Articles 4 and 5
of the New Ordinance.
7. In terms of coke furnaces which actually
exist on October 1, 1975, the furnaces will not be affected by the
provisions of Article 38-9 of the New Ordinance by March 31, 1978.
8. In terms of the application of the provisions
set forth in Articles 5 and 37 of the New Ordinance, the substances,
as set forth in (1), (2), (5), (6), (12), (13), (19), (20), (23),
(25) to (27), (29), (30), and (34) of item 2 of Attached Table 3 of
the Enforcement Order of the Industrial Safety and Health Law or the
substances, as set forth in the New Ordinance in items (1), (2), (5),
(6), (12), (13), (19), (20), (23), (25) to (27), (29), (30), and (34)
of Attached Table 1 are not to be included among group-2 substances,
as set forth in item (2) of Article 2 in the New Ordinance March 31,
1976 in spite of the provisions of the same item.
9. In terms of the application of the provisions
of Article 13 of the old Ordinance on Prevention of Hazards Due to
Specified Chemical Substances, etc., and also of Articles 18 and 21
of the New Ordinance, the facilities therein to manufacture or handle
the substances set forth in (1), (6), (12), (19), (20), (26), (29),
(30) or (34) of item 2 in Attached Table 3 of the Enforcement Order
of the Industrial Safety and Health Law or substances listed in items
(l), (6), (12), (19), (20), (26), (29), (30) or (34) of Attached Table
l in the New Ordinance are not to be included among those provided
in Article 13 of the prior-to-revision Ordinance on Prevention of
Hazards Due to Specified Chemical Substances, etc., until March 31,
1976.
Supplementary Provisions
(Ministry of Labour Ordinance No. 4 of
March 25, 1976)
(Excerpt)
(Date of Enforcement)
1.
This Ministry of Labour Ordinance will be put into effect from April
1, 1976.
Supplementary Provisions
(Ministry of Labour Ordinance No. 3 of
March 22, 1977)
This Ministry of Labour Ordinance will be put
into effect from April 1, 1977.
Supplementary Provisions
(Ministry of Labour Ordinance No. 33 of
August 16, 1978)
This Ministry of Labour Ordinance will be put
into effect from September 1, 1978.
Supplementary Provisions
(Ministry of Labour Ordinance No. 18 of
May 20, 1982)
(Excerpt)
(Date of Enforcement)
Article 1.
This ministerial ordinance shall be enforced from the day of its promulgation,
provided that the provisions of the following subparagraphs shall
be enforced from dates designated respectively in the said paragraphs.
(1) The provision to amend Article
1 of the Ordinance for Prevention of Anoxia from among the provisions
of Article 1; the provision to amend Article 2 of the said ordinance
(restricted to the part expressed as "in paragraph 1 of Article
9...", which is to be deleted, and the part to add item (2) next
to the said article); provisions to amend the provisions of Articles
3 through 5 of the said ordinance; provision to add another article
next to the said article; provisions to amend the provisions of Articles
6, 7, 9, 10, 13, 14, 16, 17 and 23 of the said ordinance; provision
to add another article next to the said article; provision to add
another article next to Article 25 of the said ordinance and the provision
to amend Article 27 of the said ordinance (restricted to the part
expressed as "anoxia" which is to be amended as "anoxia,
etc."); provision to amend item (4), paragraph 1, Article 585
of the Industrial Safety and Health Ordinance of the Industrial Safety
and Health Law out of the provisions of Article 2 and the provision
to amend item (4), paragraph 1, Article 640 of the said ordinance
(restricted to the part expressed as "the place designated in
paragraph 1 of Article 9..." in the said subparagraph, which
is to be amended as "oxygen deficiency danger place designated
in paragraph 1 of Article 9...") and Articles 4, 6 and 7 of the
supplementary provisions: July 1, 1982.
(2) (Omitted.)
(Interim Measures for Partial Amendment of the
Ordinance for Prevention of Hazards Due to Specified Chemical Substances,
etc.)
Article 7.
In applying, between July 1, 1982 and March 31, 1983, the provisions
of items (1) and (2) of paragraph 1, Article 22 of the Ordinance for
Prevention of Hazards Due to Specified Chemical Substances, etc.,
amended conforming to the provision of the preceding Article, the
part expressed as "the class-2 oxygen-deficiency-danger work
designated in item (8) of Article 2 and the work designated in Article
25-2 of the same ordinance..." shall be amended as "the
work designated in Article 25-2."
(Interim Measures for Penal Provision)
Article 8.
The penal provision to acts committed against the provision of the
old Ordinance for Prevention of Hazards Due to Specified Chemical
Substances conforming to the old Ordinance for Prevention of Anoxia,
the old Industrial Safety and Health Law and the provision of Article
6 of the Supplementary Provisions prior to the enforcement of this
ministerial ordinance shall be applied according to precedent.
Supplementary Provisions
(Ministry of Labour Ordinance No. 3 of
February 27, 1984)
(Extract)
1. This ministerial ordinance shall be enforced
from March 1, 1984.
Supplementary Provision
(Ministry of Labour Ordinance No. 8 of March 18,
1986)
This ministerial ordinance shall be enforced from
April 1, 1986.
Supplementary Provisions
(Ministry of Labour Ordinance No. 26 of September
1, 1988)
(Date of Enforcement)
Article 1.
This ministerial ordinance shall be enforced from October 1, 1988.
(The rest is omitted.)
(Interim Measures)
Article 2.
1. and 2. (Omitted).
3.
Concerning the measurements of the workplace where substances designated
in (6)of item 1 in Attached Table 3 of the Enforcement Order (Cabinet
Ordinance No. 318 of 1972) of the Industrial Safety and Health Law
and the substances designated in (1) through (4), (7), (10), (11),
(13), (16) through (18), (20) through (22), (25), (27), (28), (30),
(31) or (33) through (35) of item 2 of the said table conducted conforming
to the provision of paragraph 1 or 5, Article 65 of the Industrial
Safety and Health Law before the enforcement of this ministerial order,
the provisions of Articles 36-2 through 36-4 of the amended Ordinance
for Prevention of Hazards Due to Specified Chemical Substances, etc.,
shall not be applicable.
4. (Omitted.)
Supplementary Provisions
(Ministry of Labour Ordinance No. 30 of December
18, 1990)
This Ministry of Labour Ordinance shall be enforced
from January 1, 1991.
Supplementary Provisions
(Ministry of Labour Ordinance No. 20 of
March 30, 1994)
(Excerpts)
(Date of Enforcement)
Article 1. This Ministry of Labour Ordinance shall be enforced from
July 1, 1994.
(Interim Measures concerning Notification of Plans)
Article 2. (Omitted) Notifications based on the provisions of paragraph
1 (omitted) of Article 52 of the Ordinance on Prevention of Hazards
Due to Specified Chemical Substances, etc., prior to amendment by
this Ordinance (called the "old Specified Chemicals Ordinance"
below) concerning construction to commence after the date of enforcement
of this Ordinance (called the "Enforcement Date" below)
shall be treated as valid notifications under the provisions of paragraph
1 of Article 88 of the Industrial Safety and Health Law (called the
"Law" below) after the enforcement date.
2. (Omitted) Notifications based on the provisions of paragraph 3
(omitted) of Article 52 of the old Specified Chemicals Substances
concerning construction to commence after the enforcement date shall,
where the provisions of paragraph 2 of the Law apply, be treated as
valid notifications under the provisions of paragraph 1 of the same
Article after the enforcement date.
3. (Omitted)
4. (Omitted)
(Interim Measures concerning Penal Provisions)
Article 5. The application of penal provisions to acts committed before
the enforcement of this Ordinance and to acts committed after the
enforcement of this Ordinance that are to be treated according to
precedent under the provisions of Article 3 of the Supplementary
Provisions shall be according to precedent.
Supplementary Provisions
Ministry of Labour Ordinance
No. 3 of January 16, 1995)
(Excerpts)
(Date of Enforcement)
Article 1. This Ministry of Labour Ordinance shall be enforced from
April 1, 1995. However, the provisions listed under each of the following
items shall be enforced from the date specified in the relevant items.
(1) (Omitted) The provision in Article 2 to amend Article
36-2 of the Ordinance on Prevention of Hazards Due to Specified Chemical
Substances, etc.,: October 1, 1995.
(2) (Omitted)
(Interim Measures for Evaluating the Results of
Measurements, etc.)
Article 3. The provisions of Article 36-2 through 36-4 of the amended
Ordinance on Prevention of Hazards Due to Specified Chemical Substances,
etc., (called the "new Specified Chemicals Ordinance" below)
shall not apply to measurements in indoor workplaces of substances
listed under (6) or (14) of item 2 of Attached Table 3 of the Enforcement
Order of the Industrial Safety and Health Law (call the "Order"
below) carried out under the provisions of paragraph 1 or paragraph
5 of Article 65 of the Law before October 1, 1995.
2. The provisions of Articles 36-2 through 36-4 of the new Specified
Chemicals Ordinance shall not apply to measurements in indoor workplaces
of substances listed under (5), (19), (23), (24), (29) or (36) of
item 1 in Attached Table 3 of the Order carried out under the provisions
of paragraph 1 or 5 of Article 66 of the Law before October 1, 1996.
(Interim Measures for Penal Provisions)
Article 4. The application of penal provisions to acts committed before
the enforcement of this Ordinance shall be according to precedent.
Supplementary Provisions
(Ministry of Labour Ordinance No. 35 of September 13, 1996)
(Excerpt)
(Date of Enforcement)
Article 1. This Ministry of Labour Ordinance shall be enforced from
October 1, 1996.
Supplementary Provisions
(Ministry of Labour Ordinance No. 13 of March 25, 1997)
(Date of Enforcement)
This Ministry of Labour Ordinance shall be enforced from the date
of promulgation.
(Interim Measures)
Article 2. The application of penal provisions to acts committed prior
to the enforcement of this Ordinance shall be according to precedent.
Supplementary Provisions
(Ministry of Labour Ordinance No. 32 of October 1, 1997)
This Ministry of Labour Ordinance shall be enforced
from the date of promulgation.
Supplementary Provisions
(Ministry of Labour Ordinance No. 4 of January 11, 1999)
(Date of Enforcement)
1. This Ministry of Labour Ordinance shall be enforced from the date
of promulgation.
(Interim Measures)
2. Pre-amendment forms in existence at the time of enforcement of
this Ordinance may be altered and used for the interim period.
Attached Table 1 (related to Articles 2, 5, 36, 38-3, 38-7 and 38-8)
(1) Chemicals and other substances
containing acryl amide , provided that this does not apply in respect
to substances which contain acryl amide of 1% or less by weight.
(2) Chemicals and other substances
containing acrylonitrile, provided that this does not apply in respect
to substances which contain acrylonitrile of 1% or less by weight.
(3) Chemicals and other substances
containing alkyl mercury compounds, provided that this does not apply
in respect to substances which contain alkyl mercury compounds of
1% or less by weight
(4) Chemicals and other substances
containing asbestos (exclusive of amosite and crocidolite, the same
shall apply below in this item), provided that this does not apply
in respect to substances which contain asbestos of 1% or less by weight.
(5) Chemicals and other substances
containing ethyleneimine, provided that this does not apply in respect
to substances which contain ethyleneimine of 1% or less by weight.
(6) Chemical and other substances
containing vinyl chloride, provided that this does not apply in respect
to substances which contain vinyl chloride of 1% or less by weight.
(7) Chemicals and other substances
containing chlorine, provided that this does not apply in respect
to substances which contain chlorine of 1% or less by weight.
(8) Chemicals and other substances
containing auramine, provided that this does not apply in respect
to substances which contain auramine of 1% or less by weight.
(9) Chemicals and other substances
containing O-phthalodinitrile, provided that this does not apply in
respect to substances which contain O-phthalodinitrile of 1% or less
by weight.
(10) Chemicals and other substance
containing cadmium, provided that this does not apply in respect to
substances which contain cadmium of 1% or less by weight.
(11) Chemicals and other substances
containing chromic acid or its salts, provided that this does not
apply in respect to substances which contain chromic acid or its salts
of 1% or less by weight.
(12) Chemicals and other substances
containing chloromethyl methyl ether, provided that this does not
apply in respect to substances which contain chloromethyl methyl ether
of 1% or less by weight.
(13) Chemicals and other substances
containing vanadium pentoxide, provided that this does not apply in
respect to substances which contain vanadium pentoxide of 1% or less
by weight.
(14) Chemicals and other substances
containing coal tar, provided that this does not apply in respect
to substances which contain coal tar of 5% or less by weight.
(15) Chemicals and other substances
containing arsenic trioxide, provided that this does not apply in
respect to substances which contain arsenic trioxide of 1% or less
by weight.
(16) Chemicals and other substances
containing potassiumcyanide, provided that this does not apply in
respect to substances which contain potassium cyanide of 5% or less
by weight.
(17) Chemicals and other substances
containing hydrogencyanide, provided that this does not apply in respect
to substances which contain hydrogen cyanide of 1% or less by weight.
(18) Chemicals and other substances
containing sodiumcyanide, provided that this does not apply in respect
to substances which contain sodium cyanide of 5% or less by weight.
(19) Chemicals and other substances
containing 3-3'- dichloro-4-4'-diamino-diphenyl methane, provided
that this does not apply in respect to substances which contain 3-3'
-dichloro-4-4' - diamino-diphenyl methane of 1% or less by weight.
(20) Chemicals and other substances
containing methyl bromide, provided that this does not apply in respect
to substances which contain methyl bromide of 1% or less by weight.
(21) Chemicals and other substances
containing dichromic acid or its salts, provided that this does not
apply in respect to substances which contain dichromic acid or its
salts of 1% or less by weight.
(22) Chemicals and other substances
containing mercury or its inorganic compounds (exclusive of mercury
sulfide similarly as in the following), provided that this does not
apply in respect to substances which contain mercury or its inorganic
compounds of 1% or less by weight.
(23) Chemicals and other substances
containing trilene-diisocyanate, provided that this does not apply
in respect to substances which contain trilene-diisocyanate of 1%
or less by weight.
(24) Chemicals and other substances
containing nickel carbonyl, provided that this does not apply in respect
to substances which contain nickel carbonyl of 1% or less by weight.
(25) Chemicals and other substances
containing nitroglycol, provided that this does not apply in respect
to substances which contain nitroglycol of 1% or less by weight.
(26) Chemicals and other substances
containing P-dimethylaminoazobenzene, provided that this does not
apply in respect to substances which contain P-dimethylaminoazobenzene
of 1% or less by weight.
(27) Chemicals and other substances
containing P-nitrochlorobenzene, provided that this does not apply
in respect to substances which contain P-nitrochlorobenzene of 5%
or less by weight.
(28) Chemical and other substances
containing hydrogen fluoride, provided that this does not apply in
respect to substances which contain hydrogen fluoride of 5% or less
by weight.
(29) Chemicals and other substances
containing ?A-propiolactone, provided that this does not apply in
respect to substances which contain ?A-propiolactone of 1% or less
by weight.
(30) Chemicals and other substances
containing benzene, provided that this does not apply in respect to
substances which contain benzene of 1% or less by weight.
(31) Chemicals and other substances
containing pentachlorophenol (otherwise called PCP) or its sodium
salts, provided that this does not apply in respect to substances
which contain pentachlorophenol or its sodium salts of 1% or less
by weight.
(32) Chemicals and other substances
containingmagenta, provided that this does not apply in respect to
substances which contain magenta of 1% or less by weight.
(33) Chemicals and other substances
containing manganese or its compounds (exclusive of basic manganese
oxide, similarly as in the following), provided that this does not
apply in respect to substances which contain manganese or its compounds
of 1% or less by weight.
(34) Chemicals and other substances
containing methyl iodide, provided that this does not apply in respect
to substances which contain methyl iodide of 1% or less by weight.
(35) Chemicals and other substances
containing hydrogen sulfide, provided that this does not apply in
respect to substances which contain hydrogen sulfide of 1% or less
by weight.
(36) Chemicals and other substances
containing dimethylsulfide provided that this does not apply in respect
to substances which contain dimethylsulfide of 1% or less by weight.
Attached Table 2 (related to Article 2)
(1) Chemicals and other substances
containing ammonia, provided that this does not apply in respect to
substances which contain ammonia of 1% or less by weight
(2) Chemicals and other substances
containing carbon monoxide, provided that this does not apply in respect
to substances which contain carbon monoxide of 1% or less by weight.
(3) Chemicals and other substances
containing hydrogen chloride, provided that this does not apply in
respect to substances which contain hydrogen chloride of 1% or less
by weight.
(4) Chemicals and other substances
containing nitric acid, provided that this does not apply in respect
to substances which contain nitric acid of 1% or less by weight.
(5) Chemicals and other substances
containing sulfur dioxide, provided that this does not apply in respect
to substances which contain sulfur dioxide of 1% or less by weight.
(6) Chemicals and other substances
containing phenol, provided that this does not apply in respect to
substances which contain phenol of 5% or less by weight.
(7) Chemicals and other substances
containing phosgene, provided that this does not apply in respect
to substances which contain phosgene of 1% or less by weight.
(8) Chemicals and other substances
containing formaldehyde, provided that this does not apply in respect
to substances which contain formaldehyde of 1% or less by weight.
(9) Chemicals and other substances
containing sulfuric acid, provided that this does not apply in respect
to substances which contain sulfuric acid of 1% or less by weight.
Attached Table 3 (related to Article 39)
|
Work
|
Period
|
Items
|
|
(1) Work to manufacture or handle the substances
given below.
1) Benzidine and its salts.
2)
?A-naphthylamine and its salts.
3)
Dichlorobenzidine and its salts.
4)
??-naphthylamine and its salts.
5)
O-tolidine and its salts.
6) Dianisidine
and its salts.
7) P-dimethylamino
azobenzene.
8) Magenta.
9)
Chemicals and other substances containing these substances, listed
in item 1) to 8), of more than 1% by weight. |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as hematuria, pollakisuria,
pain on urination, etc.
3. Examination for presence of objective
or subjective symptoms such as hematuria, pollakisuria, pain
on urination, etc.
4. Microscopic examination of urine
sediment
(cytological examination by the Papanicolaou technique on urine
sediment when regarded necessary by medical doctors).
|
|
(2) Work to manufacture or handle bis (chloromethyl)
ether (inclusive of chemicals and other substances which contain
bis (chloromethyl) ether of more than 1% by weight).
|
6 months
|
1. Investigation of working history.
2 Review of past history of
presence of objective or subjective symptoms such as cough,
sputum, chest pain, body weight loss, etc., resulting from bis
(chloromethyl) ether.
3. Examination for presence of objective
or sub-jective symptoms such as cough, sputum, chest pain, body
weight loss, etc.
4. Examination with direct roentgenography
on chest on those who have been engaged in work for more than
three years.
|
|
(3) Work to manufacture or handle chlorinated
biphenyl.
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of dermatological symptoms, hepatic damage, etc., resulting
from chlorinated biphenyl.
3. Examination for presence of objective
or subjective symptoms such as appetite loss, sense of weakness,
etc.
4. Examination for presence of dermatological
findings such as hair follicle acne, darkening of skin, etc.
5. Testing for urobilinogen in urine.
|
|
(4) Work to manufacture or handle beryllium,
etc.
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of respiratory symptoms, allergic symptoms, etc., resulting
from beryllium, etc.
3. Examination for presence of objective
or subjective symptoms such as dry cough, sputum, pharyngodynia,
throat irritation, chest pain, chest uneasiness, shortness of
breath, palpitation, difficult breathing, malaise, appetite
loss, body weight loss, etc.
4. Examination for presence of dermatological
findings such as dermatitis, etc.
5. Measurement of lung vital capacities.
|
| |
1 year
|
Direct examination of chest with roentgenography.
|
|
(4-2)
Work to manufacture or handle benzotrichloride (inclusive of
chemicals and other substances which contain benzotrichloride
of more than 0.5% by weight).
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, chest
pain, nasal discharge, epistaxis, olfactory sensory loss, sinusitis,
nasal polyposis.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, chest pain, nasal
discharge, epistaxis, olfactory sensory, sinusitis, nasal polyposis,
lymph node swelling on neck, etc.
4. Examination for dermatological
findings such as verruca, pigmentation, etc.
5. Direct roentgenography examination
of chest for those were engaged in work for more than 3 years
as described in the provisions of item (9) of Article 23 of
the Enforcement Order.
|
|
(5) Work to manufacture or handle acrylamide
(inclusive of chemicals and substances which contain acrylamide
of more than 1% by weight.)
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as paresthesia in extremities,
gait disturbances, abnormal sweating, etc.
3. Examination for presence of objective
or subjective symptoms such as paresthesia in extremities, gait
disturbances, abnormal sweating, etc.
4. Examination for presence of dermatological
findings such as dermatitis.
|
|
(6) Work to manufacture or handle acrylonitrile
(inclusive of chemicals and substances which contain acrylonitrile
of more than 1% by weight.)
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, headache, irritation in upper respiratory tract, general
malaise, easy fatigue, nausea, vomiting, epistaxis, etc., resulting
from acrylonitril.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, head ache,
irritation in the upper respiratory tract, general malaise,
easy fatigue, chills, vomiting, nasal hemorrhage, etc.
|
|
(7) Work to manufacture or handle alkyl
mercury compounds (inclusive of substances which contain alkyl
mercury compounds of more than 1% of their weights.
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, headache, abnormal senses of lips or upper and lower extremities,
althralgia, insomnia, sleepiness, depression, uneasiness, disturbance
in gait, tremor in fingers, body weight loss, etc. resulting
from alkyl mercury compounds.
3. Examination for presence of objective
or subjective symptoms such as abnormal senses in lips or upper
and lower extremities, althralgia, insomnia, disturbance in
gait, tremor in fingers, body weight loss, etc.
4. Examination for presence of dermatological
findings such as dermatitis, etc.
|
|
(8) Work to manufacture or handle asbestos,
etc.
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, shortness
of breath, chest pain, etc., resulting from asbestos etc.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, shortness of breath,
chest pain, etc.
4. Direct examination of chest with
roentgenography.
|
|
(9) Work to manufacture or handle ethyleneimine
(inclusive of substances which contain ethyleneimine of more
than 1% by weight.)
|
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as headache, cough,
sputum, chest pain, vomiting, mucous irritation symptoms, etc.,
resulting from ethyleneimine.
3. Examination for presence of objective
or subjective symptoms such as headache, cough, sputum, chest
pain, vomiting, mucous irritation symptoms, etc.
4. Examination for presence of dermatological
findings such as dermatitis.
|
| (10) Work to manufacture
or handle vinyl chloride (inclusive of chemicals and substances
which contain vinyl chloride of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as general malaise,
easy fatigue, appetite loss, uncertain upper abdominal symptoms,
jaundice, tarry stools, pallidness, pain or abnormal sense in
fingers, etc. resulting from vinyl chloride.
3. Examination for presence of objective
or subjective symptoms such as headache, dizziness, tinnitus,
general malaise, easy fatigue, uncertain upper abdominal symptoms,
jaundice, tarry stools, pain or abnormal sense in fingers, etc.
4. Examination for presence of hepatomegaly
or splenomegaly.
5. Hepatic functional examination
covering items such as serum bilirubi, serum (GOT), serum (GPT),
ALP, etc.
6. Direct examination of chest with
roentgenography for those engaged in the said work for more
than 10 years.
|
| (11) Work to manufacture
or handle chlorine (inclusive of substances which contain chemicals
and the substances which contain chlorine of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as respiratory symptoms,
ophthalmologic symptoms, etc. resulting from chlorine.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, upper respiratory
tract irritation symptoms, tearing, abnormalities of corneas,
vision disturbances, dental changes, etc.
|
| (12) Work to manufacture
or handle auramine (inclusive of substances which contain suramine
of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as hematuria pollakysuria,
pain on urination, etc.
3. Examination for presence of objective
or subjective symptoms such as hematuria, pollakysuria, pain
on urination, etc.
4. Microscopic examination of urine
sediment (cytological examination by the Papanicolaou technique
on urine sediment when found necessary by medical doctors.
5. Testing for urobilinogen in urine.
|
| (13) Work to manufacture
or handle of O-phthalodinitrile (inclusive of substances which
contain O-phthalodinitrile of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as epilepsy-like attack.
3. Examination for presence of objective
or subjective symptoms such as headache, heaviness in the head,
forgetfulness, insomnia, malaise, nausea, poor appetite, facial
pallidness, tremor in fingers, etc.
4. Testing for urobilinogen in urine.
|
| (14) Work to manufacture
or handle cadmium or its compounds (inclusive of chemicals and
substances which contain cadmium or its compounds of more than
1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of symptoms such as respiratory symptoms, gastrointestinal symptoms,
etc. resulting from cadmium or its compounds.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, irritation in
throat, abnormalities in nasal mucous membranes, shortness of
breath, poor appetite, nausea, vomiting, repeated abdominal
pain or diarrhea, body weight loss, etc.
4. Examination for presence of cadmium
accumulated in yellow circles on incisor tooth or canine tooth.
5. Testing for presence of urinary
protein.
|
| (15) Work to manufacture
or handle chromic acid, etc. |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, chest
pain, abnormalities in nasal cavity, dermatological symptoms,
etc., resulting from chromic acid or bichromate.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, chest pain, etc.
4. Examination for presence (or absence)
of nasal cavity findings such as abnormalities in nasal membrane,
perforation.
5. Examination for presence of dermatological
findings such as dermatitis, ulcers, etc.
6. Direct examination of chest with
roentgenography for those engaged in work, as provided in item
(4) of Article 23 in the Enforcement Order, for more than 4
years.
|
| (16) Work to manufacture
or handle chloromethylmethylether (inclusive of chemicals and
substances which contain chloromethylmethylether of more than
1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, chest
pain, body weight loss, etc., resulting from chloromethylmethylether.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, chest pain, body
weight loss, etc.
4. Direct examination of chest with
roentgenography.
|
| (17) Work to manufacture
or handle vanadium pentoxide (inclusive of chemicals and substances
which contain vanadium pentoxide of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as respiratory symptoms,
etc., resulting from vanadium pentoxide.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, chest pain, dyspnea,
tremor in fingers, dermatological pallidness, green tongue,
cornification of the palm of fingertips, etc.
4. Measurement of lung capacity.
5. Measurement of blood pressure levels.
|
| (18) Work to manufacture
or handle coal tar (inclusive of chemicals or substances which
contain coal tar of more than 5% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as gastrointestinal
symptoms, respiratory symptoms, dermatological symptoms, etc.
resulting from coal tar.
3. Examination for presence of objective
or subjective symptoms such as poor appetite, cough, sputum,
ophthalmologic pain, etc.
4. Examination for presence of dermatological
findings such as dermatitis in exposed sites, acne changes,
melanosis, vernica, ulcers, gaseous spots, etc.
5. Direct examination of chest with
roentgenography for those engaged in work, as provided in item
(6) of Article 23 in the Enforcement Order, for more than 5
years.
|
| (19) Work to manufacture
or handle arsenic trioxide (inclusive of chemicals or substances
which contain arsenic trioxide of more then 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as abnormalities in
nasal membrane, respiratory symptoms, stomatitis, diarrhea,
constipation, body weight loss, abnormal senses, etc. resulting
from arsenic trioxide.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, poor appetite,
body weight loss, abnormal senses, etc.
4. Examination for presence of nasal
cavity findings such as abnormalities in nasal membrane, perforation
in nasal cavity, etc.
5. Examination for dermatological
findings such as dermatitis, pigmentation, depigmentation, cornification,
etc.
6. Testing for urinary urobilinogen
levels.
7. Direct examination of chest with
roentgenography for those engaged in work, as provided in item
(5) of Article 23 in the Enforcement Order, for more than 5
years.
|
(20) Work to manufacture
or handle the substances given below.
1)
Potassiumcyanide.
2) Hydrogencyanide.
3)
Sodiumcyanide.
4) Chemicals and
substances containing more than 5% by weight of the chemicals
and substances listed in l) or 3).
5)
Chemicals and other substances containing more than 1% by
weight of the substance listed in 2). |
6 months
|
1. Investigation of working history.
2. Investigation of working conditions.
3. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, headache, fatigue, malaise, hyperemia of conjunctiva,
abnormaltaste, gastrointestinal symptoms, etc.
4 Examination for presence of
objective or subjective symptoms such as heaviness in the head,
headache, fatigue, malaise, hyperemia ofconjunctiva, abnormal
taste, gastrointestinal symptoms, etc.
5 Testing of urinary urobilinogen
levels.
|
| (21) Work to manufacture
or handle 3,3'-dichloro-4,4'-diaminodiphenylmethane (inclusive
of substances which contain 3,3'-dichloro-4,4'- diaminodiphenylmethane
of more than 1% by weights.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as abnormalities in
upper abdomen, malaise, cough, sputum, chest pain, haematuria,
etc., resulting from 3-3'-dichloro-4-4'diaminodiphenylmethane.
3. Examination for presence of objective
or subjective symptoms such as abnormalities in upper abdomen,
malaise, cough, sputum, chest pain, haematuria, etc.
4. Hepatic functional examination.
|
| (22) Work to manufacture
or handle methyl bromide (inclusive of chemicals or substances
which contain methyl bromide of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, headache, dizziness, tearing, rhinitis, throat pain, cough,
poor appetite, nausea, vomiting, abdominal pain, diarrhea, paresthesia
in upper and lower extremities, decreased sight, decreased memory,
dysarthria, increased reflex in tendon, disturbances in gait,
etc., resulting from methyl bromide.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, headache,
dizziness, poor appetite, paresthesia in upper and lower extremities,
decreased sight, decreased memory, dysarthria, increased reflex
in tendon, disturbances in gait, etc.
4 Examination for the presence
of dermatological findings.
|
| (23) Work to manufacture
or handle mercury or its inorganic compounds (inclusive of chemicals
and substances which contain mercury or its inorganic compounds
of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as headache, insomnia,
tremor in fingers, oliguria, polyuria, inflammation of gums,
stomatitis, etc., resulting from mercury or its inorganic compounds.
3. Examination for presence of objective
or subjective symptoms such as headache, insomnia, tremor in
fingers, oliguria, polyuria, inflammation of gums, stomatitis,
etc., resulting from mercury or its inorganic compounds.
4. Examination for presence of urinary
occult blood and protein.
|
| (24) Work to manufacture
or handle trilenediisocyanate (inclusive of chemicals and other
substances which contain trilenediisocyanate of more than 1% by
weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as headache, ophthalmologic
pain, nasal pain, throat pain, abnormal feeling in throat, cough,
sputum, sense of chest compression, shortness of breath, chest
pain, dyspnea, general malaise, mucous inflammation in eyes,
nose, or throat, body weight loss, allergic asthma, etc., resulting
from trilenediisocyanate.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, headache,
ophthalmologic pain, nasal pain, throat pain, abnormal feeling
in throat, cough, sputum, chest compression sense, shortness
of breath, chest pain, dyspnea, general malaise, mucous inflammation
in eyes, nose or throat, body weight loss, allergic asthma,
etc.
4. Examination for presence of dermatological
findings such as dermatitis.
|
| (25) Work to manufacture
or handle nickel carbonyl (inclusive of chemicals and other substances
which contain nickel carbonyl of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as headache, dizziness,
nausea, vomiting, cough, chest pain, dyspnea, itching, abnormalities
in nasal mucous membrane, etc. resulting from nickel carbonyl.
3. Examination for presence of objective
or subjective symptoms such as headache, dizziness, nausea,
vomiting, cough, chest pain, dyspnea, itching, abnormalities
in nasal mucous membrane, etc.
|
| |
1 year
|
Direct examination of chest with
roentgenography.
|
| (26) Work to manufacture
or handle nitroglycol (inclusive of chemicals and other substances
which contain nitroglycol of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as headache, abnormal
feeling in the chest, cardiac symptoms, paresthesia in upper
and lower extremities, cooling sensation, neuralgia, malaise,
etc. resulting from nitroglycol.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, headache,
stiffness in shoulders, abnormal feeling in the chest, cardiac
symptoms, paresthesia in upper and lower extremities, cooling
sense, neuralgia, malaise, gastrointestinal symptoms, etc.
4. Measurement of blood pressure levels.
5. Testing of blood in respect to
its total specific gravity, and erythrocytic systems covering
blood count of red blood cells, etc.
|
| (27) Work to manufacture
or handle P-nitrochlorobenzene (inclusive of chemicals or substances
which contain P-nitrochlorobenzene of more than 5% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, headache, dizziness, malaise, fatigue, facial pallidness,
cyanosis, anemia, palpitations, coloured urine, etc.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, headache,
dizziness, malaise, fatigue, facial pallidness, cyanosis, anemia,
palpitation, coloured urine, etc.
4. Testing for urinary urobilinogen.
|
| (28) Work to manufacture
or handle hydrogen fluoride (inclusive of chemicals or substances
which contain hydrogen fluoride of more than 5% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as respiratory symptoms,
ophthalmologic symptoms, etc., resulting from hydrogen fluoride.
3. Examination for presence of objective
or subjective symptoms such as mucous inflammation of the eyes,
noseor mouth, change in tooth colour, etc.
4. Examination for presence of dermatological
findings such as dermatitis.
5. Testing for urinary urobilinogen.
|
| (29) Work to manufacture
or handle β -propiolactone (inclusive of chemicals
and substances which contain β-propiolactone of more
than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, chest
pain, body weight loss, etc. resulting from β-propiolactone.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, chest pain, body
weight loss, etc.
4. Examination for dermatological
findings such as dermatitis in exposed sites.
5. Direct examination of chest with
roentgenography.
|
| (30) Work to manufacture
or handle benzene, etc. |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, headache, dizziness, palpitation, malaise, paresthesia
in upper and lower extremities, poor appetite, bleeding tendency,
etc. resulting from benzene.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, headache,
dizziness, palpitation, malaise, paresthesia in upper and lower
extremities, poor appetite, etc.
4. Testing of blood in respect to
the total specific gravity, and erythrocytic systems covering
blood count of red blood cells, etc.
5. Testing for blood count of white
blood cells.
|
| (31) Work to manufacture
or handle pentachlorophenol (otherwise called PCP) or its sodium
salts (inclusive of chemicals and substances which contain pentachlorophenol
and its sodium salts of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, throat
pain, irritation in throat, headache, dizziness, easy fatigability,
malaise, gastrointestinal symptoms such as poor appetite, preference
for sweet materials, excessive sweating, fever, palpitation,
ophthalmologic pain, itching, etc., resulting from pentachlorophenol
or its sodium salts.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, throat pain, irritation
in throat, headache, dizziness, easy fatigability, malaise,
gastrointestinal symptoms such as poor appetite, preference
for sweets, excessive sweating, ophthalmologic pain, itching,
etc.
4. Examination for presence of dermatological
findings such as dermatitis, etc.
5. Measurement of blood pressure levels.
6. Testing of urinary sugar and urobilinogen.
|
| (32) Work to manufacture
or handle manganese or its compounds (inclusive of manganese or
its compounds) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as cough, sputum, mask-like
faces, salve faces, ptyalismus, abnormal sweating, tremors in
the fingers, unskillful lettering, disturbances in gait, disturbances
of involuntary motion, dysarthria, etc., as in Parkinson's syndrome.
3. Examination for presence of cough,
sputum, mask-like face, salve faces, ptyalismus abnormal sweating,
tremor in fingers, unskillful lettering, disturbances in gait,
disturbances of involuntary motion, dysarthria as symptoms as
in Parkinson's syndrome.
4. Measurement of grasping power.
|
| (33)
Work to manufacture or handle methyl iodide (inclusive of chemicals
and other substances which contain methyl iodide of more than
1%) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as heaviness in the
head, dizziness, sleepiness, nausea, vomiting, malaise, dimness
of sight, etc., resulting from methyl iodide.
3. Examination for presence of objective
or subjective symptoms such as heaviness in the head, dizziness,
sleepiness, nausea vomiting, malaise, dimness of sight, etc.
4. Examination for presence of dermatological
findings such as dermatitis.
|
| (34) Work to manufacture
or handle hydrogen sulfide (inclusive of chemicals and other substances
which contain hydrogen sulfide of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as respiratory symptoms,
ophthalmologic symptoms, etc., resulting from hydrogen sulfide.
3. Examination for presence of objective
or subjective symptoms such as headache, sleeplessness, easy
fatigability, dizziness, easy excitability, nausea, cough, upper
respiratory tract irritation, gastrointestinal symptoms, abnormalities
in conjunctiva and cornea, changed teeth.
|
| (35) Work to manufacture
or handle dimethyl sulfide (inclusive of chemicals and other substances
which contain dimethyl sulfide of more than 1% by weight.) |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as respiratory symptoms,
ophthalmologic symptoms, dermatological symptoms, etc., resulting
from dimethyl sulfide.
3. Examination for presence of objective
or subjective symptoms such as cough, sputum, hoarseness, tearing,
abnormalities in conjunctivaand cornea, senses of powerlessness,
gastrointestinal symptoms, etc.
4. Examination for presence of dermatological
findings such as dermatitis, etc.
5. Testing of urinary urobilinogen
or protein.
|
(36) Work to manufacture
or handle the substances given below, for use in experimentation
and research.
1) 4-aminodiphenyl
and its salts.
2) 4-nitrodiphenyl
and its salts.
3) Chemicals and
other substances which contain substances listed in items 1) and
2) more than 1% by weight. . |
6 months
|
1. Investigation of working history.
2. Review of past history of presence
of objective or subjective symptoms such as hematuria, pollakysuria,
pain on urination, etc.
3. Examination for presence of objective
or subjective symptoms such as hematuria, pollakysuria, pain
on urination, etc.
4. Microscopic examination of urine
sediment (cytological examination by the Papanicolaou technique
on urine sediment when found necessary by medical doctors.)
|
Attached Table 4 (related to Article 39)
|
Type of work
|
Items
|
|
(1) Work to manufacture or handle the substances
given below.
1) Benzidine or its salts
2) β-naphthylamine and its salts.
3) α-naphthylamine and its salts.
4) P-dimethylaminoazobenzene.
5) Chemicals and other substances which contain
substances listed in items 1) to 4) of more than 1% by weight. |
1. Investigation into working conditions.
2. Cystoscopy or pyelography, when
found necessary by medical doctors.
|
|
(2) Work to manufacture or handle the substances
given below.
1) Dichlorobenzidine or its salts.
2) O-tolidine and its salts.
3) Dianisidine and its salts.
4) Magenta.
5) Chemicals and other substances which contain
substances listed in items 1) to 4) of more than 1% by weight. |
1. Investigation into working conditions.
2. Cystoscopy, when found necessary
by medical doctors.
|
|
(3) Work to manufacture or handle bis (chloromethyl)
ether (inclusive of chemicals and other substances which contain
bis (chloromethyl) ether of more than 1% by weight.
|
1. Investigation into working conditions.
2. Examination of chest with specified
roentgenography, cytological examination on sputum or bronchoscopy
when found necessary by medical doctors.
|
|
(4) Work to manufacture or handle chlorinated
biphenyl, etc.
|
1. Investigation into working conditions.
2. Blood testing of erythrocytic system
such as total specific gravity, blood count of red blood cells,
etc.
3. Testing for blood count of white
blood cells.
4. Hepatic functional examination.
|
|
(5) Work to manufacture or handle beryllium,
etc.
|
1. Investigation into working conditions.
2. Chest physical examination.
3. Pulmonary ventilation function
examination.
4. Pulmonary functional diffusion
examination, ECC, measurement of urinary or blood beryllium
levels, dermatological patching test, or measurement of hematocrit
values, when found necessary by medical doctors.
|
|
(5-2)
Work to manufacture or handle benzotrichloride (inclusive of
chemicals and other substances which contain benzotrichloride
of more than 0.5% by weight.)
|
1. Investigation into working conditions.
2. Examination of chest with specified
roentgenography, cytological examination on sputum, bronchoscopy,
examination with cerebral roentgenography, etc., blood testing
(inclusive of blood clinical pictures), histopathological examination
of lymphatic gland or dermatological histopathological examination,
when found necessary by medical doctors.
|
|
(6) Work to manufacture or handle acrylamide
(inclusive of chemicals and other substances which contain acrylamide
of more than 1% by weight.)
|
1. Investigation into working conditions.
2. Medical and neurological examination
of peripheral nerves.
|
|
(7) Work to manufacture or handle acrylonitrile
(inclusive of chemicals and other substances which contain acrylonitrile
of more than 1% by weight.)
|
1. Investigation into working conditions.
2. Measurement of plasma cholinesterase
action values.
3. Hepatic functional examination.
|
|
(8) Work to manufacture or handle alkyl
mercury compounds (inclusive of chemicals and other substances
which contain alkyl mercury compounds of more than 1% by weight.)
|
1. Investigation into working conditions.
2. Measurement of blood and urinary
mercury levels.
3. Examination for presence of stenosis
of visual fields.
4. Checking hearing.
5. Medical neurological examination
of abnormal senses, Rombergsign, inability to do repeatedly
antagonistic motions, etc.
6. EMG and EEG when found necessary
by medical doctors in a case in which abnormal neurological
findings are noted.
|
|
(9) Work to manufacture or handle asbestos,
etc.
|
1. Investigation into working conditions.
2. When the results of direct examination
of chest with roentgenography show abnormal shadows (exclusive
of fibrous growth change), examination of chest with specific
roentgenography, cytological examination on sputum, and bronchoscopy,
when found necessary by medical doctors.
|
| (10) Work to manufacture
or handle ethyleneimine (inclusive of chemicals and other substances
which contain ethyleneimine of more than 1% by weight.) |
1. Investigation into working conditions.
2. Counting of bone marrow cells.
3. Examination of chest with direct
or specific roentgenography, cytological examination, bronchoscopy
or renal functional examination, when found necessary by medical
doctors.
|
| (11) Work to manufacture
or handle vinyl chloride (inclusive of chemical and other substances
which contain vinyl chloride of more than 1% by weight.) |
1. Investigation into working conditions.
2. Testing for platelet counts, gamma
gultamiltraspepitase (?A-GTP) and Kunkel's reactions (ZTT) when
hepatomegaly or splenomegaly are noted.
3. Examination with dianogreen method
(ICG), testing for lactate dehydrogenase (LDH), testing for
serum lipid levels, etc., examination with specific roentgenography,
examination of liver or spleen with scintigram, and medical
neurological examination of central nervous systems, when found
necessary by medial doctors.
|
| (12) Work to manufacture
or handle chlorine (inclusive of chemicals and other substances
which contain chlorine of more than 1% by weight.) |
1. Investigation into working conditions.
2. Chest physical examination or examination
of chest with direct roentgenography.
3. Pulmonary ventilation function
examination when objective or subjective symptoms are noted
in respiratory organs.
|
| (13) Work to manufacture
or handle auramine (inclusive of the chemicals and other substances
which contain auramine of more than 1% by weight.) |
1. Investigation into working conditions.
2. Cystoscopy or hepatic functional
examination, when found necessary by medical doctors.
|
| (14) Work to manufacture
or handle O-phthalodinitrile (inclusive of chemicals and other
substances which contain O-phthalodinitrile of more than 1% by
weight.) |
1. Investigation into working conditions.
2. Blood testing of erythrocytic system
covering total specific gravity, blood count of red blood cells,
etc.
3. EEG when abnormal findings such
as epilepsy-like attack are noted in cerebral nervous systems.
4. Hepatic functional tests or measurement
of urinary phthalic acid levels when gastrointestinal symptoms
are noted and when found necessary by medical doctors.
|
| (15) Work to manufacture
or handle cadmium or its compounds (inclusive of chemicals and
other substances which contain cadmium of more than 1% by weight.) |
1. Investigation into working conditions.
2. Measurement of urinary cadmium
levels.
3. Chest physical examination and
pulmonary ventilation function examination when objective or
subjective symptoms are noted in respiratory organs.
4. Urine sedimentation tests, measurement
of urinary protein levels, and renal functional examinations
when urinary protein is noted.
|
| (16) Work to manufacture
or handle chromic acid, etc. |
1. Investigation into working conditions.
2. Examination of chest with direct
or specific roentgenography, cytological examination on sputum,
bronchoscopy or dermatological pathological examination, when
found necessary by medical doctors.
|
| (17) Work to manufacture
or handle chloromethylmethlyether (inclusive of chemicals and
substances which contain chloromethylmethylether of more than
1% by weight.) |
1. Investigation into working conditions.
2. Examination of chest with direct
or specific roentgenography, cytological examination on sputum,
or bronchoscopy, when found necessary by medical doctors.
|
| (18) Work to manufacture
or handle vanadium pentoxide (inclusive of chemicals and other
substances which contain vanadium pentoxide of more than 1% by
weight.) |
1. Investigation into working conditions.
2. Examination of sight.
3. Chest physical examination or examination
of chest with direct roentgenography.
4. Examination of pulmonary ventilation
functions, measurement of serum cholesterol or triglyceride,
or measurement of urinary vanadium, when found necessary by
medical doctors.
|
| (19) Work to manufacture
or handle coal tar (inclusive of chemicals and other substances
which contain coal tar of more than 5% by weight.) |
1. Investigation into working conditions.
2. Examination of chest with direct
or specific roentgenography, cytological examination on sputum,
bronchoscopy, or dermato-pathological examination, when found
necessary by medical doctors.
|
| (20) Work to manufacture
or handle arsenic trioxide (inclusive of chemicals and other substances
which contain arsenic trioxide of more than 1% by weight.) |
1. Investigation into working conditions.
2. Examination of chest with direct
or specific roentgenography, measurement of hair or urinary
arsenic levels, hepatic functional test, blood testing of erythrocytic
system, cytological examination on sputum, bronchoscopy, or
dermato-pathological examination, when found necessary by medical
doctors.
|
| (21) Work to manufacture
or handle 3,3' -dichloro-4,4' - diaminodiphenyl methane (inclusive
of chemicals and other substances which contain 3,3' -dichloro-4,4'
- diaminodiphenyl methane of more than 1% by weight.) |
1. Investigation into working conditions.
2. Examination of chest with direct
or specific roentgenography, cytological examination on sputum,
bronchoscopy, or renal functional examination, when found necessary
by medical doctors.
|
| (22) Work to manufacture
or handle methyl bromide (inclusive of chemicals and substances
which contain methyl bromide of more than 1% by weight.) |
1. Investigation into working conditions.
2. Examination of motor function,
visual acuity, visual field, or EEG, when found necessary by
medical doctors.
|
| (23) Work to manufacture
or handle mercury or its inorganic compounds (inclusive of chemicals
and other substances which contain mercury or its inorganic compounds
of more than 1% by weight.) |
1. Investigation into working conditions.
2. Neurological examination.
3. Measurement of urinary mercury
levels and urinary sediments tests.
|
| (24) Work to manufacture
of handle trilenediisocyanate (inclusive of chemicals and other
substances which contain trilene- diisocyanate of more than 1%
by weight.) |
1. Investigation into working conditions.
2. Physical examination of chest,
examination of chest with direct roentgenography, or examination
of occlusive changes of respiratory functions when existing
subjective or objective symptoms of lungsare noted.
3. Hepatic function tests, renal function
tests, or examination of allergic reaction when found necessary
by medical doctors.
|
| (25) Work to manufacture
or handle nickel carbonyl (inclusive of chemicals and other substances
which contain nickel carbonyl of more than 1% by weight.) |
1. Investigation into working conditions.
2. Examination of pulmonary ventilation
functions.
3. Physical examination of chest.
4. Measurement of urinary or blood
nickel levels when found necessary by medical doctors.
|
| (26) Work to manufacture
or handle nitroglycol (inclusive of chemicals and other substances
which contain nitroglycol of more than 1% by weight.) |
1. Investigation into working conditions.
2. Measurement of urinary or blood
nitroglycol levels.
3. Blood testing on the two items
out of the measurement of hematocrit values, blood count of
red blood cells and measurement of hemoglobin, when abnormalities
were found as a result of the testing of blood total specific
gravity.
4. Testing for the presence of urinary
urobilinogen and of protein.
5. Examination with ECG.
6. Examination of automatic nervous
systems (exclusive of that conducted with drugs), hepatic functional
examination, and circulatory functional examinationwhen found
necessary by medical doctors.
|
| (27) Work to manufacture
or handle P-nitrochlorobenzene (inclusive of chemicals and other
substances which contain P-nitrochlorobenzene of more than 5%
by weight.) |
1. Investigation into working conditions.
2. Blood testing of erythrocytic system
covering blood total specific gravity, blood count of red blood
cells, reticulocytes count, methemoglobin levels and the presence
of Heinz body.
3. Testing for urinary occult blood.
4. Hepatic function examination.
5. Neurological examination.
6. Measurement of urinary aniline
or P-aminophenol or measurement of metabolites in blood such
as nitrosoamine and hydroxyamine, aminophenol, quinone-imine,
etc., when found necessary by medical doctors.
|
| (28) Work to manufacture
or handle hydrogen fluoride (inclusive of chemicals and other
substances which contain hydrogen fluoride of more than 5% by
weight.) |
1. Investigation into working conditions.
2. Chest physical examination or examination
of chest with direct roentgenography.
3. Blood testing of erythrocytic system
covering total blood specific gravity, blood count of red blood
cells, etc.
4. Measurement of bleeding time, examination
of long bones with roentgenography, hepatic function examination,
measurement of urinary fluorine, or measurement of blood acidic
phosphatase or calcium when found necessary by medical doctors.
|
| (29) Work to manufacture
or handle β-propiolactone (inclusive of chemicals and other
substances which contain betapropiolactone of more than 1% by
weight) |
1. Investigation into working conditions.
2. Examination of chest with specific
roentgenography, cytological examination on sputum, bronchoscopy,
and dermato-pathological examination when found necessary by
doctors.
|
| (30) Work to manufacture
or handle benzene, etc. |
1. Investigation into working conditions.
2. Scanning in terms of blood covering
blood pictures and others.
3. Neurological examination.
|
| (31) Work to manufacture
or handle pentachlorophenol (otherwise called PCP) or its sodium
salts (inclusive of chemicals and other substances which contain
pentachlorophenol of more than 1% by weight) |
1. Investigation into working conditions.
2. Chest physical examination and
examination of chest with direct roentgenography when objective
or subjective symptoms are noted in respiratory organs.
3. Hepatic function examination.
4. Blood count of white blood cells.
5. Measurement of urinary pentachlorophenol,
when found necessary by medical doctors.
|
| (32) Working to manufacture
or handle manganese or its compounds (inclusive of chemicals and
other substances which contain manganese or its compounds of more
than 1% by weight) |
1. Investigation into working conditions.
2. Chest physical examination and
examination of chest with direct roentgenography when objective
or subjective symptoms are noted in respiratory organs.
3. Neurological examination for Parkinson's-syndrome-like
symptoms.
4. Measurement of urinary or blood
manganese levels, when found necessary by medical doctors.
|
| (33) Work to manufacture
or handle methyl iodide (inclusive of chemicals and other substances
which contain methyl iodide of more than 1% by weight) |
1. Investigation into working conditions.
2. Ophthalmologic examination, motor
neuron function examination, or neurological examination when
found necessary by medical doctors.
|
| (34) Work to manufacture
or handle hydrogen sulfide (inclusive of chemicals and other substances
which contain hydrogen sulfide of more than 1% by weight) |
1. Investigation into working conditions.
2. Chest physical examination or examination
of chest with direct roentgenography.
|
| (35) Work to manufacture
or handle dimethyl sulfide (inclusive of chemicals and other substances
which contain dimethyl sulfide of more than 1% by weight) |
1. Investigation into working conditions.
2. Chest physical examination or examination
of chest with direct roentgenography.
3. Hepatic function tests, renal function
tests or examination of pulmonary ventilation functions, when
found necessary by medical doctors.
|
(36) Work to manufacture
or handle the chemicals given below, for use in experimentation
and research.
1) 4-aminodiphenyl
and its salts.
2) 4-nitrodiphenyl
and its salts.
3) Chemicals and
other substances which contain substances listed in 1) and 2)
of more than 1% by weight. |
1. Investigation into working conditions.
2. Cystoscopy or pyelography, when
found necessary by medical doctors.
|
Attached Table 5 (related to Article 39)
(1) Chemicals and other substances
containing asbestos (exclusive of amosite and crocidolite, the same
shall apply below in this item), provided that this does not apply
in respect to substances which contain asbestos of 1% or less by weight.
(2) Chemicals and other substances
containing ethyleneimine, provided that this does not apply in respect
to substances which contain ethyleneimine of 5% or less by weight.
(3) Chemicals and other substances
containingvinyl chloride, provided that this does not apply in respect
to substances which contain vinyl chloride of 1% or less by weight.
(4) Chemicals and other substances
containing auramine, provided that this does not apply in respect
to substances which contain auramine of 1% or less by weight.
(5) Chemicals and other substances
containing chromic acid or its salts, provided that this does not
apply in respect to substances which contain chromic acid or its salts
of 1% or less by weight.
(6) Chemicals and other substances
containing chloromethylmethylether, provided that this does not apply
in respect to substances which contain chloromethylmethylether of
1% or less weight.
(7) Chemicals and other substances
containing coal tar, provided that this does not apply in respect
to substances which contain coal tar of 5% or less by weight.
(8) Chemicals and other substances
containing arsenic trioxide, provided that this does not apply in
respect to substances which contain arsenic trioxide of 1% or less
weight.
(9) Chemicals and other substances
containing 3.3'-dichloro-4.4'-diaminodiphenylmethane, provided that
this does not apply in respect to substances which contain 3-3'-dichloro-4-4'-diaminodiphenylmethane
of 1% or less by weight.
(10) Chemicals and other substances
containing dichromic acid or its salts, provided that this does not
apply in respect to substances which contain dichromic acid or its
salts of 1% or less by weight.
(11) Chemicals and other substances
containing nickel carbonyl, provided that this does not apply in respect
to substances which contain nickel carbonyl of 1% or less by weight.
(12) Chemicals and other substances
containing P-dimethylaminoazobenzene, provided that this does not
apply in respect to substances which contain P-dimethylaminoazobenzene
of 1% or less by weight.
(13) Chemicals and other substances
containing ?A-propiolactone, provided that this does not apply in
respect to substances which contain ?A-propiolactone of 1% or less
by weight.
(14) Chemicals and other substances
containing benzene, provided that this does not apply in respect to
substances which contain benzene of 1% or less by weight.
(15) Chemicals and other substances
containingmagenta, provided that this does not apply in respect to
substances which contain magenta of 1% or less by weight.
(Deleted)
Notice on Performance, as Provided by the Minister of Labour on the
Basis of item (5) of Article 7 and f) of item (7) in paragraph 1 of
Article 50 of the Ordinance on Prevention of Hazards Due to Specified
Chemical Substances, etc.
Ministry of Labour Notice No. 75 (September 30,
1975)
Revised into Notice 26, March 25, 1976.
The performance standards given below are established
by the Minister of Labour in relation to item (5) of Article 7 (inclusive
of the cases in which paragraph 2 of Article 38-12 is applicable to
the said item) and to f) of item (7) in paragraph 1 of Article 50
(inclusive of the cases in which paragraph 2 of Article 50-2 is applicable
to this item) of the Ordinance on Prevention of Hazards Due to Specified
Chemical Substances.
(1) In terms of local exhaust ventilation
systems installed in workshops therefrom to disperse gases, vapour,
or dust resulting from the substances listed in (3) or (6) of item
1, or the substances as described in (8) of the same item which are
related to (3) or (6) of the same item, or the substances listed in
(1) to (7) inclusive, (9) to (11) inclusive, (13) to (18) inclusive,
(20) to (25) inclusive, (27), (28), (30), (31) or (33) to (36) inclusive
of item 2 of Attached Table 3 of the Enforcement Order of the Industrial
Safety and Health Law, or the substances listed in item (1) to (7)
inclusive, (9) to (11) inclusive, (13) to (18) inclusive, (20) to
(25) inclusive, (27) (28), (30), (31) or (33) to (36) inclusive of
Attached Table 1 of the Ordinance on Prevention of Hazards Due to
Specified Chemical Substances, the concentrations of substances, as
described in (3) or (6) of item 1 of Attached Table 3 of the Enforcement
Order of the Industrial Safety and Health Law or the substances listed
in (1) to (7), (9) to (11) inclusive, (13) to (18) inclusive, (20)
to (25) inclusive, (27), (28), (30), (31) or (33) to (36) inclusive
of item 2 of Attached Table 3 of the said Enforcement Order
outside the hoods of local exhaust ventilation systems shall be not
more than the values as established in the right column of the Table
as given below corresponding to the types of the substances listed
in the left column of the same Table.
|
Types of substances
|
Values
|
|
Chlorinated biphenyl (otherwise known as
PCB)
|
0.5 mg.
|
|
Beryllium and its compounds
|
0.002 mg.
|
|
Acrylamide
|
0.3 mg.
|
|
Acrylonitrile
|
45 mg. or 20 cm3
|
|
Alkyl mercury compounds (restricted to the
substances in which the alkyl radicals are methyl or ethyl radicals).
|
0.01 mg.
|
|
Asbestos
|
5
|
|
Ethyleneimine
|
1 mg. or 0.5 cm3
|
|
Vinyl chloride
|
2 cm3
|
|
Chlorine
|
3 mg. or 1 cm3
|
|
O-Phthalodinitrile
|
0.1 mg.
|
|
Cadmium and its compounds
|
0.05 mg.
|
|
Chromic acid and its salts
|
0.1 mg.
|
|
Vanadium pentoxide
|
In terms of substances in powder: 0.5 mg.,
In terms of substances in gaseous form:
0.05 mg.
|
|
Coal tar
|
0.2 mg.
|
|
Arsenic trioxide
|
0.5 mg.
|
|
Potassium cyanate
|
5 mg.
|
|
Hydrogen cyanate
|
11 mg. or 10cm3
|
|
Sodium cyanate
|
5 mg.
|
|
Methyl bromide
|
60 mg. or 15 cm3
|
|
Dichromic acid and its salts
|
0.1 mg.
|
|
Mercury and its inorganic compounds (exclusive
of mercurysulfide)
|
0.05 mg.
|
|
Trilenediisocyanate
|
0.12 mg. or 0.02 cm3
|
|
Nickel carbonyl
Nitroglycol
|
0.007 mg. or 0.001 cm3
1.2mg. or 0.2cm3
|
|
P-Nitrochlorobenzene
|
1 mg.
|
| |
|
|
Hydrogen fluoride
|
2 mg. or 3 cm3
|
|
Benzene
|
30 mg. or 10 cm3
|
|
Pentachlorophenol (otherwise known as PCP)
and its sodium salts
|
0.5 mg.
|
|
Manganese and its compounds (exclusive of
basic manganese oxides)
|
5 mg.
|
|
Methyl iodide
|
28 mg. or 5 cm3
|
|
Hydrogen sulfide
|
15 mg. or 10 cm3
|
|
|
|
top